The purpose of this study is to evaluate the effect of a combination of the 21 mg nicotine
patch and very low nicotine content (VLNC) cigarettes compared to 21 mg nicotine patch only
and very low nicotine content cigarette only on abstinence, time to relapse and toxicant
levels. The study will determine if adding nicotine replacement medication to the very low
content cigarettes (VLNC) will augment treatment compared to nicotine patch only or to very
low nicotine content cigarettes only.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute